These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7692588)

  • 1. Intravenous drug abuse--the major route of hepatitis C virus transmission among alcohol-dependent individuals?
    Verbaan H; Andersson K; Eriksson S
    Scand J Gastroenterol; 1993 Aug; 28(8):714-8. PubMed ID: 7692588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease.
    Befrits R; Hedman M; Blomquist L; Allander T; Grillner L; Kinnman N; Rubio C; Hultcrantz R
    Scand J Gastroenterol; 1995 Nov; 30(11):1113-8. PubMed ID: 8578173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors--the role of parenteral and sexual transmission.
    Shev S; Hermodsson S; Lindholm A; Malm E; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(2):99-104. PubMed ID: 7544914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse.
    Bassily S; Hyams KC; Fouad RA; Samaan MD; Hibbs RG
    Am J Trop Med Hyg; 1995 Jun; 52(6):503-5. PubMed ID: 7541968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.
    Holsen DS; Harthug S; Myrmel H
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):673-6. PubMed ID: 7694850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C virus in alcoholic patients: role of parenteral risk factors.
    Galperim B; Cheinquer H; Stein A; Fonseca A; Lunge V; Ikuta N
    Arq Gastroenterol; 2006; 43(2):81-4. PubMed ID: 17119659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C virus antibodies in alcoholic patients].
    González Quintela A; Alende R; Aguilera A; Tomé S; Gude F; Pérez Becerra E; Torre A; Martínez Vázquez JM; Barrio E
    Rev Clin Esp; 1995 Jun; 195(6):367-72. PubMed ID: 7644783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1.
    Corona R; Prignano G; Mele A; Gentili G; Caprilli F; Franco E; Ferrigno L; Giglio A; Titti F; Bruno C
    Epidemiol Infect; 1991 Dec; 107(3):667-72. PubMed ID: 1661241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrafamilial transmission of hepatitis C virus in Japan.
    Michitaka K; Onji M; Horiike N; Kajino K; Saito I; Miyamura T; Ohta Y
    Gastroenterol Jpn; 1991 Oct; 26(5):619-22. PubMed ID: 1721596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of antibody to hepatitis C virus in 177 drug addicts].
    Ye S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Feb; 14(1):45-8. PubMed ID: 8389248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease in anti-hepatitis C virus-positive Norwegian blood donors.
    Nordøy I; Schrumpf E; Elgjo K; Flesland O; Andersen Glende J; Orjasaeter H; Siebke JC
    Scand J Gastroenterol; 1994 Jan; 29(1):77-81. PubMed ID: 8128181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.